• 1
    Agostinis, P., K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. M. Hahn, M. R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B. C. Wilson and J. Golab (2011) Photodynamic therapy of cancer: An update. CA Cancer J. Clin. 61, 250281.
  • 2
    Senge, M. O. and J. C. Brandt (2011) Temoporfin (Foscan(R), 5,10,15,20-tetra(m-hydroxyphenyl)chlorin), a second generation photosensitizer. Photochem. Photobiol. 87, 12401296.
  • 3
    Fahr, A. and X. Liu (2007) Drug delivery strategies for poorly water-soluble drugs. Expert Opin. Drug. Deliv. 4, 403416.
  • 4
    Derycke, A. S. and P. A. de Witte (2004) Liposomes for photodynamic therapy. Adv. Drug Deliv. Rev. 56, 1730.
  • 5
    Semple, S. C., A. Chonn and P. R. Cullis (1998) Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. Adv. Drug Deliv. Rev. 32, 317.
  • 6
    Ishida, T., H. Harashima and H. Kiwada (2002) Liposome clearance. Biosci. Rep. 22, 197224.
  • 7
    Hwang, K. J. and P. L. Beaumier (1988) Disposition of liposomes in vivo. In Liposomes as Drug Carriers: Recent Trends and Progress. (Edited by G. Gregoriadis), pp. 1927. Wiley, Chichester, New York.
  • 8
    Obochi, M. O. K., R. W. Boyle and J. E. v. Lier (1993) Biological activities of phthalocyanines. XIII. The effects of human serum components on the in vitro uptake and photodynamic activity of zinc phthalocyanine. Photochem. Photobiol. 57, 634640.
  • 9
    Reshetov, V., D. Kachatkou, T. Shmigol, V. Zorin, M.-A. D’Hallewin, F. Guillemin and L. Bezdetnaya (2011) Redistribution of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from conventional and PEGylated liposomes to biological substrates. Photochem. Photobiol. Sci. 10, 911919.
  • 10
    Hefesha, H., S. Loew, X. Liu, S. May and A. Fahr (2011) Transfer mechanism of temoporfin between liposomal membranes. J. Control Release 150, 279286.
  • 11
    Kuntsche, J., I. Freisleben, F. Steiniger and A. Fahr (2010) Temoporfin-loaded liposomes: Physicochemical characterization. Eur. J. Pharm. Sci. 40, 305315.
  • 12
    Kachatkou, D., S. Sasnouski, V. Zorin, T. Zorina, M. A. D’Hallewin, F. Guillemin and L. Bezdetnaya (2009) Unusual photoinduced response of mTHPC liposomal formulation (Foslip). Photochem. Photobiol. 85, 719724.
  • 13
    Lowry, O. H., N. J. Rosebrough, A. L. Farr and R. J. Randall (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265275.
  • 14
    Tietz, N. W. (1995) Clinical Guide to Laboratory Tests. WB Saunders Co., Philadelphia.
  • 15
    Malloy, A. and B. Carr (2006) Nanoparticle tracking analysis—The Halo™ system. Part. Part. Syst. Charact. 23, 197204.
  • 16
    Silvander, M., M. Johnsson and K. Edwards (1998) Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum. Chem. Phys. Lipids 97, 1526.
  • 17
    Kessel, D., P. Thompson, K. Saatio and K. D. Nantwi (1987) Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine. Photochem. Photobiol. 45, 787790.
  • 18
    Maziere, J. C., P. Morliere and R. Santus (1991) The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. J. Photochem. Photobiol. B 8, 351360.
  • 19
    Richter, A. M., E. Waterfield, A. K. Jain, A. J. Canaan, B. A. Allison and J. G. Levy (1993) Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem. Photobiol. 57, 10001006.
  • 20
    Jori, G. (1990) Factors controlling the selectivity and efficiency of tumour damage in photodynamic therapy. Lasers Med. Sci. 5, 115120.
  • 21
    Ginevra, F., S. Biffanti, A. Pagnan, R. Biolo, E. Reddi and G. Jori (1990) Delivery of the tumour photosensitizer zinc(II)-phthalocyanine to serum proteins by different liposomes: Studies in vitro and in vivo. Cancer Lett. 49, 5965.
  • 22
    Michael-Titus, A. T., R. Whelpton and Z. Yaqub (1995) Binding of temoporfin to the lipoprotein fractions of human serum. Br. J. Clin. Pharmacol. 40, 594597.
  • 23
    Hopkinson, H. J., D. I. Vernon and S. B. Brown (1999) Identification and partial characterization of an unusual distribution of the photosensitizer meta-tetrahydroxyphenyl chlorin (temoporfin) in human plasma. Photochem. Photobiol. 69, 482488.
  • 24
    Sasnouski, S., V. Zorin, I. Khludeyev, M. A. D’Hallewin, F. Guillemin and L. Bezdetnaya (2005) Investigation of Foscan interactions with plasma proteins. Biochim. Biophys. Acta 1725, 394402.
  • 25
    Blake, G. J., J. D. Otvos, N. Rifai and P. M. Ridker (2002) Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 106, 19301937.
  • 26
    El Harchaoui, K., B. J. Arsenault, R. Franssen, J. P. Despres, G. K. Hovingh, E. S. Stroes, J. D. Otvos, N. J. Wareham, J. J. Kastelein, K. T. Khaw and S. M. Boekholdt (2009) High-density lipoprotein particle size and concentration and coronary risk. Ann. Intern. Med. 150, 8493.
  • 27
    Bonneau, S., P. Morliere and D. Brault (2004) Dynamics of interactions of photosensitizers with lipoproteins and membrane-models: Correlation with cellular incorporation and subcellular distribution. Biochem. Pharmacol. 68, 14431452.
  • 28
    Loew, S., A. Fahr and S. May (2011) Modeling the release kinetics of poorly water-soluble drug molecules from liposomal nanocarriers. J. Drug Deliv. 2011, Article ID 376548.
  • 29
    Chowdhary, R. K., I. Shariff and D. Dolphin (2003) Drug release characteristics of lipid based benzoporphyrin derivative. J. Pharm. Pharm. Sci. 6, 1319.
  • 30
    Compagnin, C., F. Moret, L. Celotti, G. Miotto, J. H. Woodhams, A. J. Macrobert, D. Scheglmann, S. Iratni and E. Reddi (2011) Meta-tetra(hydroxyphenyl)chlorin-loaded liposomes sterically stabilised with poly(ethylene glycol) of different length and density: Characterisation, in vitro cellular uptake and phototoxicity. Photochem. Photobiol. Sci. 10, 17511759.
  • 31
    Scherphof, G., F. Roerdink, M. Waite and J. Parks (1978) Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins. Biochim. Biophys. Acta 542, 296307.
  • 32
    Tall, A. R., I. Tabas and K. J. Williams (1986) Lipoprotein–liposome interactions. Methods Enzymol. 128, 647657.
  • 33
    Comiskey, S. J. and T. D. Heath (1990) Serum-induced leakage of negatively-charged liposomes at nanomolar lipid concentrations. Biochemistry 29, 36263631.
  • 34
    Scherphof, G. L., J. Damen and J. Wilschut (1984) Interactions of liposomes with plasma proteins. In Liposome Technology, Vol. 3 (Edited by G. Gregoriadis), pp. 205224. CRC Press, Boca Raton, Fla.
  • 35
    Harashima, H., Y. Ochi and H. Kiwada (1994) Kinetic modelling of liposome degradation in serum: Effect of size and concentration of liposomes in vitro. Biopharm. Drug Dispos. 15, 217225.
  • 36
    Madörin, M., P. van Hoogevest, R. Hilfiker and H. Leuenberger (2000) The use of fluorescence resonance energy transfer to study the disintegration kinetics of liposomes containing lysolecithin and oleic acid in rat plasma. Pharm. Res. 17, 11181123.
  • 37
    Dos Santos, N., C. Allen, A. M. Doppen, M. Anantha, K. A. Cox, R. C. Gallagher, G. Karlsson, K. Edwards, G. Kenner, L. Samuels, M. S. Webb and M. B. Bally (2007) Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: Relating plasma circulation lifetimes to protein binding. Biochim. Biophys. Acta 1768, 13671377.
  • 38
    Foradada, M., A. Manzano, T. Roig, J. Estelrich and J. Bermúdez (1997) Serum-liposome interaction is an oxygen-dependent process. Biochim. Biophys. Acta 1345, 4355.
  • 39
    Braeckmans, K., K. Buyens, W. Bouquet, C. Vervaet, P. Joye, F. De Vos, L. Plawinski, L. Doeuvre, E. Angles-Cano, N. N. Sanders, J. Demeester and S. C. De Smedt (2010) Sizing nanomatter in biological fluids by fluorescence single particle tracking. Nano Lett. 10, 44354442.
  • 40
    Filipe, V., A. Hawe and W. Jiskoot (2010) Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res. 27, 796810.
  • 41
    Nagayasu, A., K. Uchiyama and H. Kiwada (1999) The size of liposomes: A factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv. Drug Deliv. Rev. 40, 7587.
  • 42
    Oku, N., Y. Tokudome, Y. Namba, N. Saito, M. Endo, Y. Hasegawa, M. Kawai, H. Tsukada and S. Okada (1996) Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography. Biochim. Biophys. Acta 1280, 149154.
  • 43
    Scherphof, G. and H. Morselt (1984) On the size-dependent disintegration of small unilamellar phosphatidylcholine vesicles in rat plasma. Evidence of complete loss of vesicle structure. Biochem. J. 221, 423429.
  • 44
    Jung, S. H., S. K. Kim, E. H. Kim, S. H. Cho, K. S. Jeong, H. Seong and B. C. Shin (2010) Increased stability in plasma and enhanced cellular uptake of thermally denatured albumin-coated liposomes. Colloids Surf. B Biointerfaces 76, 434440.